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he Spore Coat Protein CotE Facilitates Host Colonization 
by Clostridium di cile
Huynh A. Hong,1,a William T. Ferreira,1,a Siamand Hosseini,1 Saba Anwar,1 Krisztina Hitri,1 Anthony J. Wilkinson,2 Wilfried Vahjen,3  
Jürgen Zentek,3 Mikhail Soloviev,1 and Simon M. Cutting1
1School of Biological Sciences, Royal Holloway, University of London, Surrey, and 2Department of Chemistry, University of York, United Kingdom; and 3Institute for Animal Health, 
Freie University of Berlin, Germany
Clostridium di cile infection (CDI) is an important hospital-acquired infection resulting from the germination of spores in the 
intestine as a consequence of antibiotic-mediated dysbiosis of the gut microbiota. Key to this is CotE, a protein displayed on the 
spore surface and carrying 2 functional elements, an N-terminal peroxiredoxin and a C-terminal chitinase domain. Using isogenic 
mutants, we show in vitro and ex vivo that CotE enables binding of spores to mucus by direct interaction with mucin and contributes 
to its degradation. In animal models of CDI, we show that when CotE is absent, both colonization and virulence were markedly 
reduced. We demonstrate here that the attachment of spores to the intestine is essential in the development of CDI. Spores are usually 
regarded as biochemically dormant, but our indings demonstrate that rather than being simply agents of transmission and dissem-
ination, spores directly contribute to the establishment and promotion of disease.
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Clostridium di cile is a Gram-positive, spore-forming human 
and animal pathogen and one of the leading causes of nosoco-
mial antibiotic-associated diarrhoea in developed countries [1]. 
he disease results from antibiotic-induced dysbiosis of the gut 
microlora that allows spores of C. di cile to germinate, prolif-
erate, and produce at least 2 inlammatory cytotoxins (toxins 
A and B), resulting in tissue damage [2, 3]. It has been demon-
strated that vegetative cell adherence is important and a number 
of adhesins have been found, including SlpA [4], lagellin [5], 
and Cwp84 [6]. However, whether it is necessary for the spore 
to attach to the intestine prior to germination is unknown.
During the acute stage of infection, there is transient pro-
duction of enormous numbers of spores (approximately 6 logs 
higher than the infective dose) in the intestine [7]. However, the 
number of spores produced can vary signiicantly for diferent 
strains. A number of clues suggest that the spore may contribute 
to C. di cile infection (CDI). First, hamsters challenged with 
spores of a non-toxigenic strain of C. di cile (CD1342) expe-
rienced cell damage in the cecum as well as an inlammatory 
response [8]. Second, Kansau et al [9] found that in a mouse 
model, the sporulation process of hypervirulent strain R20291 
was initiated earlier compared to non-hypervirulent strains. 
Finally, a C. di cile spo0A mutant that cannot produce spores 
was shown to be unable to persist within, and efectively trans-
mit disease between mice [10].
Other than being an agent of transmission, an intriguing 
question that has not been addressed is whether the spore per se 
plays a role in the development of disease. he outermost layer 
of the spore carries a number of enzymes, but the CotE pro-
tein is particularly interesting [11]. It is an 81-kDa bifunctional 
protein that carries 2 distinct domains, an N-terminal perox-
iredoxin domain and a C-terminal chitinase domain [11, 12]. 
he peroxiredoxin domain resembles a 1-Cys peroxiredoxin, 
suggesting it may be involved in reducing hydrogen peroxide 
arising as a by-product of SodA-mediated cross-linking of spore 
coat proteins [11]. he chitinase domain, belonging to the gly-
cohydrolase family 18, might prima facie play a nutritional role 
in the turnover of macromolecules such as chitin. Intriguingly, 
CotE may have a more sophisticated function and contribute 
directly to pathogenesis.
In this article, we show in vitro that CotE enables spore adhe-
sion to mucus via direct binding to the mucin glycoproteins 
GlcNAc and GalNAc. Our in vivo data demonstrate that spore 
attachment is important for developing CDI and that CotE is 
required for eicient intestinal colonization. Surprisingly, CotE 
increased the severity of CDI in a hamster model; animals dosed 
with spores lacking CotE exhibited signiicantly delayed symp-
toms of CDI. Taken together we suggest that CotE, and thus the 
spore, plays an integral role in attachment to the gut mucosa to 
initiate the infection and the ensuing virulence of CDI, a inding 
that is both important and hitherto unnoticed.
M A J O R  A R T I C L E
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of 
America. This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted 
reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI: 10.1093/infdis/jix488
Received 13 July 2017; editorial decision 8 September 2017; accepted 12 September 2017; pub-
lished online September 15, 2017.
aH. A. H. and W. T. F. contributed equally to this work.
Correspondence: S. M. Cutting, School of Biological Sciences, Royal Holloway, University of 
London, Egham, Surrey, UK (s.cutting@rhul.ac.uk).
Downloaded from https://academic.oup.com/jid/article-abstract/216/11/1452/4159306
by University of York user
on 21 March 2018
C. difficile Colonization • JID 2017:216 (1 December) • 1453
METHODS
Strains, Reagents, and General Methods
Two wild-type strains of C.  di cile were used in this work: 
630Δerm and 630. he 630Δerm strain is a spontaneously cured 
derivative of 630 (tcdA+ tcdB+) that is erythromycin sensitive 
[13]; 630 (erythromycin resistant) was isolated from a patient 
with pseudomembranous colitis during an outbreak of CDI [14]. 
he 630 strain is used in animal experiments as the 630Δerm 
strain is sensitive to clindamycin. Two previously described [12] 
cotE ClosTron mutants, isogenic to 630Δerm, were used: ET46 
(cotE::CT220s) and ET24 (cotE::CT1203s). A  sigK ClosTron 
mutant JP051 (sigK::CT266s) carrying an insertion ater codon 
87 of the coding open reading frame was constructed in this 
laboratory and will be described elsewhere. he CotE mutants 
were complemented with wild-type copies of the respective 
genes using pRPF185 as described previously [12]. All spores 
used were puriied through a 20%–50% Histodenz gradient. 
Expression of CotE on the spore surface was veriied by Western 
blotting (Supplementary Figure 1C). Antibodies (mouse) recog-
nizing the N-terminus of CotE (M1-K234) have been described 
previously [12] while antibodies to the C-terminus of CotE 
were raised in mice by 3 intraperitoneal injections of rCotEC 
(P381-F712) (Supplementary Figure  1). Methods for growth 
and sporulation of C. di cile and previously described methods 
are shown in the Supplementary Methods.
Adhesion of Spores to HT29-MTX Cells
he method was performed as described previously [15]. In 
brief, cells were seeded at 4 × 104 cells/well in 24-well plates for 
14 days at 37°C with 7.5% carbon dioxide. On the day of exper-
imentation, cells were washed once with phosphate-bufered 
saline (PBS). Spores were added to the wells and incubated for 2 
hours at 37°C. Non-adherent spores were removed by washing 
with PBS 5-times and cells lysed with Triton X-100 (0.1% w/v) 
in PBS for 10 minutes before enumeration of adherent spores 
by plating on brain heart infusion broth supplemented with 
yeast extract, cysteine and sodium taurocholate (BHISS) plates. 
Percentage adhesion was calculated using the formula [% adhe-
sion = (colony-forming units [CFU] count / initial number of 
spores added) × 100]. Data were presented as the percentage 
proportion of binding demonstrated by strain 630 spores. For 
antibody-blocking adhesion experiments; the same procedure 
as described above was used, but spores were preincubated with 
anti-CotEC antibody (1/10) for 30 minutes at 37°C before add-
ing to the wells.
Ligand Binding
High binding enzyme-linked immunosorbent assay (ELISA) 
plates were coated with ligands conjugated to human serum 
albumin (Dextra, Reading, United Kingdom) at a concentra-
tion of 10 µg/mL overnight at 4°C. For mucin, porcine stomach 
type III (M1778, Sigma), a solution was made fresh in PBS (pH 
7.4) and used to coat plates at 1 µg/mL (overnight at 4°C). Ater 
blocking the plate with 2% (v/v) bovine serum albumin (BSA) 
in PBS (1 hour at 30°C), recombinant proteins (rCotEN or rCo-
tEC) were diluted in 1% (v/v) BSA at a concentration of 0.5 μM 
and incubated for 2.5 hours at 30°C. rCotEN (mouse) and rCo-
tEC (mouse) were used as primary antibodies and anti-mouse 
immunoglobulin G–horseradish peroxidase (DAKO P0447) 
was used as the secondary antibody.
Mucin Degradation
hree milliliters of sterile molten 0.5% (w/v) agarose containing 
0.5% (w/v) of mucin (porcine type III, Sigma M1778) was over-
laid onto sterile microscope slides (76 × 26 mm) rapidly. he 
sterile slide was placed into a petri dish and the agarose let to 
solidify, ater which 3-mm-diameter holes were punched out of 
the medium. Ten microliters of spores (1 × 1010/mL) was added 
to the wells. he petri dished was closed and sealed with parailm 
and incubated for 48 hours at 37°C. Before staining with amido 
black solution for 30 minutes (Sigma A8181), the agarose was 
compressed to a thin layer using a 500-g weight (30 minutes with 
Whatman No. 3 between agarose and weight). he slide was then 
de-stained several times with 7% (v/v) acetic acid.
Animal Experiments
All animal procedures were performed under the UK Home 
Oice project license PPL 70/8276. For animal experiments, we 
followed methods from those described previously [15, 16].
Hamsters
Female Golden Syrian Hamsters were 16–18 weeks old (Harlan 
UK Ltd). For the hamster challenge, animals were dosed by 
intragastric gavage (i.g.) with clindamycin (clindamycin-2-phos-
phate, Sigma) 30 mg/kg body weight. Ater 16 hours, they were 
dosed i.g. with spores or vegetative cells of wild-type or mutant 
strains. Animals were monitored for symptoms of disease pro-
gression and culled upon reaching the clinical endpoint. he 
symptoms of CDI were scored as severe/clinical endpoint (wet 
tail >2 cm, high lethargy), mild (wet tail <2 cm), or healthy. Feces 
were sampled daily and ceca taken from culled animals.
Mice
he 50% infectious dose (ID
50
) was determined in mice (6–8 
weeks old, female, Harlan UK Ltd) as described previously [17]. 
Animals were dosed i.g. with clindamycin (30 mg/kg) and chal-
lenged with spores (101, 102, and 103 CFU) of strain 630 or cotE 
mutants. Ceca were removed 24 hours post-infection and col-
onization was deined by the presence of toxins and spore CFU 
counts 2 logs higher than the initial dose.
Statistical Analysis
Statistical analysis was calculated and signiicance determined 
(P < .05) using the Welch t test for unequal variance. All statis-
tical analyses were performed using GraphPad Prism sotware.
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RESULTS
Generation of CotE Mutants and Their Complements
Two mutants of cotE and their complements have been 
described previously [12]. cotE::CT220s carries an inser-
tion (cotE::CT220s) at the N-terminus preceding both the 
peroxiredoxin and chitinase domains, while the insertion 
in cotE::CT1203s is centrally positioned and precedes the 
C-terminal chitinase domain (Supplementary Figure  1A). 
For simplicity, these mutants will be described here as CotE– 
(cotE::CT220s) and CotEC– (cotE::CT1203s). To demonstrate 
the integrity of both mutants, we showed that each carried 2 cop-
ies of the erm gene, whereas the isogenic 630Δerm parent strain 
carried 1 copy (Supplementary Figure 1B). his conirmed the 
presence of 1 ClosTron insertion on the chromosome, which we 
further veriied using DNA sequencing. herefore, the pheno-
types we observe for the 2 cotE mutants can be directly assigned 
to the absence of CotE or of course due to a pleiotropic efect 
(eg, disruption or missassembly of the spore coat resulting from 
the absence of an intact CotE). Using polyclonal antisera raised 
in mice to the N-terminal (residues 1–234) and C-terminal 
(residues 381–712) domains of CotE, we conirmed that neither 
mutant produced CotE (Supplementary Figure  1C). In previ-
ous work, we have reported a pRPF185-CotE complementation 
plasmid that carried full-length cotE [12]. he cotE mutant cells 
carrying this plasmid produced spores that expressed CotE 
(Supplementary Figure  1D). Functional complementation of 
the CotE mutant phenotype was demonstrated in this work and 
is described in more detail below.
CotE Enables Binding of Spores to Mucus
Adhesion of mutant and wild-type spores to mucus was evalu-
ated using the HT29-MTX human cell line that secretes MUC2 
mucins typically found in the small and large intestine and 
therefore more physiologically relevant for studies of pathogen–
mucus interactions [18]. Wild-type 630Δerm spores exhibited 
higher levels of adhesion (15%–20%) to HT29-MTX cells 
compared to both cotE mutants, which showed signiicantly 
(P < .001) lower levels of adhesion (Figure 1A). In cotE mutant 
strains carrying the pRPF185-CotE plasmid, levels of adhe-
sion were equivalent to wild type demonstrating functional, in 
trans, complementation of the CotE phenotype. Image analysis 
of antibody-labeled spores adhering to HT29-MTX cell lines 
(day 14) was also used to conirm that wild-type spores were 
more abundant on mucus-producing HT29-MTX monolayers 
(Supplementary Figure  2). In a second, ex vivo, approach we 
measured adhesion of wild-type and mutant spores to ileum 
and cecum biopsies obtained from a piglet (Supplementary 
Figure  3). For both cotE mutants, spore adhesion to ileum 
and cecum explants was signiicantly reduced compared with 
adhesion of wild-type spores at both incubation times. A fur-
ther experiment, conirming that cotE is involved in binding of 
spores to mucus, was performed using wild-type spores prein-
cubated with antibodies recognizing the C-terminal domain of 
cotE before being added to HT29-MTX cells. he data showed 
that adhesion of wild-type spores could be signiicantly reduced 
by preadsorption with CotE antibodies (Figure 1B).
CotE Mediates Spore Binding to Mucin and Enhances Colonization
To dissect CotE’s ainity for mucus, we used an ELISA-based 
method to examine binding of recombinant CotE protein 
fragments to mucin, the main component of mucus, as well as 
GlcNAc and GalNAc. GlcNAc is the repeating unit in chitin 
and is also present in mucin glycoproteins [19] and glycosylated 
proteins present on intestinal epithelial cells [20]. GalNAc is 
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Figure 1. CotE is essential for spore binding to mucus-producing HT29-MTX cells. A, Spores of wild-type (630Δerm, cotE+), cotE–, and cotEC– isogenic strains or cotE 
mutants carrying the pRPF185-CotE plasmid were added to mucus-producing HT29-MTX monolayers (multiplicity of infection of 100:1) aged 14 days. Non-adherent spores 
were removed by washing and the adherent spores were determined by plating on brain heart infusion broth supplemented with yeast extract, cysteine and sodium tauro-
cholate agar. The experiment was independently repeated 3-times. Error bars represent standard deviations. **P ≤ .01, ***P ≤ .001 by the Welch unequal variance t test. B, 
Spores of 630Δerm (CotE+) were preincubated with anti-CotEC antibody or naive serum before adding to HT29-MTX cells. Non-adherent spores were removed by washing, 
and adherent spores were determined by plating on BHISS agar. Data for untreated spores and spore incubated with naive of anti-CotEC serum are shown. The experiment 
was independently repeated 3 times. Error bars represent standard deviations.
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the C4 epimer of GlcNAc and is found (together with GlcNAc) 
in mucin. We observed signiicantly more binding of rCo-
tEC, comprising the C-terminal chitinase domain, to mucin, 
GlcNAc, and GalNAc compared to rCotEN that carried the 
N-terminal peroxiredoxin domain (Figure 2).
In many pathogenic bacteria, binding to mucus and mucin 
is a mechanism for attachment to the intestinal epithelium and 
host colonization [19, 21]. We hypothesize that CotE enables 
C. di cile spores to accomplish the same. To address this, we 
determined the ID
50
 of mutants in a murine model (Table  1) 
as previously described by Phetcharaburanin et al [17]. In this 
model, animals do not show symptoms of disease, and colo-
nization is measured by the presence of toxin and CFU (2–3 
logs higher CFU than initial dose) in the cecum. Wild-type 630 
spores had an ID
50
 of 101 whereas values for the cotE– (103) and 
cotEC– (102.3) mutants were 1–2 logs higher, demonstrating that 
CotE had a role in the ability of spores to infect and colonize 
the host.
CotE Facilitates Degradation of Mucin
Chitin-binding proteins in bacteria can also function as muco-
lytic enzymes and therefore we investigated CotE for this trait 
[22, 23]. Using a modiied mucin degradation assay [24], we 
showed mucin degradation mediated by CotE. Ater 48 hours of 
incubation, a zone or halo of mucin degradation was observed 
in amido black–stained mucin agarose wells containing wild-
type spores (Figure  3). By contrast, very limited degrada-
tion was apparent in wells containing an identical number of 
spores for either of the cotE mutants. his phenotype, however, 
was restored in cotE mutant spores carrying pRPF185-CotE. 
Vegetative cells of C.  di cile have been shown previously to 
be unable to degrade mucin [25], and we have conirmed this 
also with our wild-type and mutant strains (data not shown). 
Degradation of mucin by CotE was conirmed using luores-
cently labeled mucin and reverse-phase high-performance liq-
uid chromatography analysis (Supplementary Figure 4).
CotE Enhances Virulence of CDI in Hamsters
Degradation of mucin by intestinal pathogenic bacteria has 
been shown to contribute to virulence [19]. Accordingly, we 
investigated the efect of CotE on virulence using the hamster 
model of infection [26]. In this model, the colonization of the 
host can be observed from speciic symptoms, or the presence 
of toxins and/or spore CFU in the cecum or feces. Virulence 
is relected by survival rate and/or by the time from coloniza-
tion to clinical endpoint (severe symptoms). In both mutants, 
17% of hamsters were not colonized and survived until the end 
of the experiment (10 days) whereas with wild type, 100% of 
hamsters were colonized and eventually succumbed to infec-
tion (Figure 4A). While the time from colonization to clinical 
endpoint for 630 was approximately 6 hours, with CotE– and 
CotEC– the time was 28 and 27 hours, respectively (Figure 
4B). Interestingly, among colonized hamsters (5/6), there was 
1 hamster from each of the mutant groups which was positive 
for toxin in feces but developed no symptoms and only reached 
clinical endpoint ater approximately 90 hours (Figure 4B). 
At 82 hours post-inoculation, 100% of hamsters infected with 
strain 630 spores had reached clinical endpoint, whereas with 
cotE– and cotEC– only 34% and 50%, respectively, had become 
moribund (Figure 5A–C). Once hamsters reached clinical end-
point, ceca were checked to conirm the presence of toxins and 
C. di cile spores at roughly equivalent levels between groups 
(Supplementary Figure 5). To rule out the possibility that the 
delay in symptoms and morbidity of hamsters could be due 
to a diference in toxin production, we checked the kinetics of 
toxin production both in vitro and in vivo and conirmed that 
they were of essentially equivalent levels between all 3 strains 
(Supplementary Figure 6). he germination rate of the mutant 
and wild-type spores has also been checked and conirmed to 
be the same (Supplementary Figure 7). he reduced virulence 
of cotE mutant spores observed here in hamsters has been inde-
pendently repeated (Supplementary Figure 8).
To investigate whether sporulation afects virulence, we 
used vegetative cells of wild type and a sporulation defective 
sigK– mutant to infect hamsters following the same dos-
ing regime as that used above with spores. Mutation of sigK 
(encoding a sporulation-speciic sigma factor controlling 
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Figure 2. CotE binds to mucin via GlcNAc and GalNAc. The binding of proteins 
corresponding to the N-terminal (rCotEN) and C-terminal (rCotEC) domains of CotE 
to mucin or ligands was measured by enzyme-linked immunosorbent assay (ELISA). 
Mucin or ligands were irst coated onto ELISA plates and either rCotEN or rCotEC 
then applied. Bound protein, after washing, was measured by ELISA. The exper-
iment was independently repeated 3 times. Error bars represent standard devia-
tions. ***P ≤ .001 by the Welch unequal variance t test. Abbreviation: OD
450
, optical 
density 450 nm.
Table 1. The 50% Infectious Dose of Clostridium difficile Strain 630 and 
Mutant Spores in a Murine Modela
Strain 50% Infectious Dose
CotE+ 101
CotE– 103
CotEC– 102.3
aMice are considered positive for Clostridium difficile infection when cecum tests positive 
for toxin and colony-forming units 2 logs higher than initial dose.
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spore coat biosynthesis [27]) will afect the terminal stages of 
sporulation-speciic gene expression in the mother cell cham-
ber and, unlike spoOA, is less likely to exert pleiotropic efects 
on expression of additional virulence genes. While it took 72 
hours for all strain 630–infected hamsters to reach clinical end-
point, 168 hours was required for all sigK– infected animals 
to succumb (Figure  6). Since hamsters dosed with sigK– cells 
exhibited delayed mortality, we ruled out the possibility of dif-
ferential toxin production in vivo by measuring toxin kinetics 
in mice (Supplementary Figure 9). Note that in cecum samples, 
a low spore CFU count was found as the sigK– mutant being 
oligosporogenous is presumably able to produce a very low 
level (approximately 4 logs less than 630 per gram of feces) of 
functional spores (Figure 6) [28]. hese results suggest that (i) 
spores contribute to the virulence of CDI, and (ii) CotE, and 
potentially additional spore-associated proteins, are involved in 
colonization.
DISCUSSION
Our study provides important insights into the role of the spore 
in CDI: irst, that the spore is responsible for initial colonization 
by targeting and binding mucus enabling the establishment of 
infection and, second, that the spore is an active agent in the 
acute stage of infection. Although an interaction of the spore 
with mucus might not be unexpected, we can now attribute 
this to at least 1 spore-associated protein, CotE, a bifunctional 
peroxiredoxin/chitinase that is embedded in the outermost lay-
ers of the spore. What is surprising is that this spore enzyme is 
functionally active and able to bind directly to mucin mono-
mers (the glycoproteins GlcNAc and GalNAc) and directly or 
indirectly facilitate mucin degradation. Some chitinases are 
thought to degrade mucus [22], and chitin binding proteins 
are considered colonization factors that have been found in 
several other important pathogens including Listeria monocy-
togenes [29], Legionella pneumophila [30], and Escherichia coli 
[31]. In each case, the proteins are secreted and have a direct 
role in virulence, colonization, and infection. Vibrio cholerae is 
a well-studied example where 2 proteins, GbpA and ChiA2 (1 
of 2 chitinases in V. cholerae), act synergistically to bind and 
degrade both chitin and mucin. GbpA is a chitin-binding pro-
tein that is able to recognize GlcNAc present in chitin as well as 
on the surface of epithelial cells, enabling colonization of host 
cells by V. cholerae [21].
he adhesion of intestinal pathogenic bacteria to the gas-
trointestinal tract is a crucial aspect of host colonization as it 
prevents them being mechanically cleared [32]. In the case of 
C. di cile, the spore is the transmissible entity and here we show 
that for the successful establishment of infection, the spore must 
also adhere to the host. Interestingly, heriot et al demonstrated 
that, within the small intestine, spores are able to germinate 
CotE+ CotEC– (pRPF185)  CotE– (pRPF185)  CotE–
 CotEC–
Figure 3. CotE promotes degradation of mucin. Mucin degradation assays for wild-type (630Δerm), cotE mutants, and complemented strains (carrying pRPF185-CotE). 
Spores were applied to wells cut in agarose containing mucin and were incubated aerobically for 48 h at 37°C before staining with amido black.
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Figure 4. Absence of CotE slows progression of Clostridium dificile infection. Groups of hamsters (n = 6) were administered clindamycin and, 16 h later, dosed by intra-
gastric gavage with spores (102) of C. dificile 630 (wild-type, cotE+), cotE–, and cotEC–. A, Kaplan–Meier survival. B, Time from initial symptoms (wet tail and/or presence of 
fecal toxins) to clinical endpoint (virulent phase) are shown. Note that 1 hamster from each mutant group was not colonized and did not show symptoms.
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regardless of antibiotic perturbation [33]. It is therefore possible 
that spores are able to initiate colonization in the small bowel in 
the absence of microbiota disruption and that an intact micro-
biota is required to suppress vegetative C. di cile outgrowth to 
prevent clinical disease. Hong et al recently found that muco-
sal antibodies against the C-terminal of toxin A also recognize 
the spore and vegetative cells of C. di cile and prevents CDI in 
hamsters by blocking colonization [15]. We demonstrate that 
the spore binds to the gastrointestinal tract prior to germination 
to initiate CDI via interactions mediated by CotE. In our study, 
animals (both mice and hamsters) infected with spores lacking 
CotE show a marked reduction in colonization. It is important 
to consider that several adhesins may be responsible for initial 
spore attachment. In support of this, Phetcharaburanin et  al 
identiied hair-like appendages comprised of the BclA1 protein 
that make “irst contact” with the host mucosa [17]. However, 
this study saw no diferences between the severity of CDI caused 
by mutant BclA1 and wild-type 630 in hamsters.
In our study, spores appear able to enhance the severity of 
disease once initial colonization has been established. his is 
clear from hamster studies showing that the time required to 
develop symptoms in colonized animals was markedly delayed 
in animals dosed with spores devoid of CotE. To explain this, 
we can envisage several scenarios. One possible explanation 
could be that by degrading mucus, CotE facilitates transit of 
toxins to the underlying epithelial cells and so mucin deg-
radation is an integral step in pathogenesis. Another possi-
bility is that the severity of disease is due to the combined 
action of toxins and spores interacting with the large number 
of macrophages and neutrophils produced during the acute 
stages of infection leading to the production of inlammatory 
cytokines [3]. In support of this we have shown, in vitro, that 
spores are inlammatory and that this response is signiicantly 
reduced in the absence of CotE (Supplementary Figure 10). 
he spore acting as a virulence factor has been shown in 
Bacillus anthracis where a spore surface superoxide dismutase 
enhances virulence by as much as 40-fold in a mouse model 
of anthrax [34].
Over the past decade, a multitude of studies have been con-
ducted to understand the severity of epidemic and hyperviru-
lent 027/B1/NAP1 strains, but precise causative mechanisms 
have yet to be found and links between high sporulation rates 
and hypervirulence remain inconclusive [35, 36]. A direct role 
for the spore in acute infection has implications for the con-
cept of hypervirulence, a phenomenon that so far lacks clar-
ity. Most compelling are recent in vivo studies showing (i) 
increased persistence of hypervirulent 027 strains (R20291) in 
the gastrointestinal tract [17] and (ii) increased levels of intes-
tinal sporulation that correlated with increased severity of dis-
ease [9]. Using isogenic strains, we show that administration 
of cells of a sigK mutant that exhibits very low levels of spores 
results in an extended period of infection, post-colonization. 
One straightforward explanation is that increased spore num-
bers together with greater intestinal persistence exacerbate 
symptoms of CDI by CotE-mediated mucin degradation and/
or inlammation.
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